Insights from 2023 ASH Annual Meeting


 

Final 48-Week Results of the APPLY-PNH Trial: Long-Term Efficacy & Safety in Anti-C5-Treated Patients With PNH & Persistent Anemia Undergoing Factor B Inhibition With Oral Iptacopan Monotherapy

304 views
April 3, 2024
Comments 0
Login to view comments. Click here to Login